UNII-KN712V27AV; ethyl 2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetate; Ethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate; ethyl (1,1-dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetate; KN712V27AV; CHEMBL3125563; Ethyl2,3-dihydro-3-oxo-1,2-benzisothiazole-2-acetate-1,1-dioxide; Ethyl 2-(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)acetate; Piroxicam impurity E [EP]; Saccharin N-(2-Acetic Acid Ethyl Ester)(Piroxicam Impurity E); (Piroxicam Impurity E)'; ChemDiv1_000366; EC 607-416-7; Oprea1_631494; Oprea1_858121; SCHEMBL14884779; CTK8G3035; HMS588A14; DTXSID50179412; HMS3429B03; ZINC297517; BBL023194; BDBM50496460; MFCD00688886; STK136579; 1,2-Benzisothiazole-2(3H)-acetic acid, 3-oxo-, ethyl ester, 1,1-dioxide; AKOS000418951; CCG-113731; MCULE-1359837935; (1,1,3-Trioxo-1,3-dihydro-1lambda*6*-benzo[d]isothiazol-2-yl)-acetic acid ethyl; CS-0127725; FT-0674495; ST50227434; T7571; SR-01000398864; SR-01000398864-1; Q27282339; Ethyl 3-oxo-1,2-benzoisothiazoline-2-acetate 1,1-dioxide; ethyl 2-(1,1,3-trioxo-2-hydrobenzo[d]isothiazol-2-yl)acetate; Benzo[d]isothiazol-3-one, 2-(2-ethoxy-2-oxoethyl)-, 1,1-dioxide; Ethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate #; ethyl 2-(1,1,3-trioxo-2,3-dihydro-1lambda6,2-benzothiazol-2-yl)acetate